All In Biotech

Drug Trial Radar · NCT03575104

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder

Last checked: Nov 19, 2026Latest source record: Mar 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 924 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

924

Actual

Start

May 29, 2018

Primary completion

Apr 9, 2020

Study completion May 14, 2020

Sponsor

Lead sponsor
Idorsia Pharmaceuticals Ltd.Industry
Sponsor type
Industry
First posted
Jul 2, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess efficacy and safety of ACT-541468 (daridorexant) in adult and elderly subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.

Conditions

  • Insomnia Disorder

Interventions

  • DaridorexantDrug

    Daridorexant will be administered as tablets, orally, once daily in the evening.

  • PlaceboOther

    Matching placebo will be administered as tablets, orally, once daily in the evening.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Month 1 in Wake After Sleep Onset (WASO) (Sleep Maintenance)Time frame: From baseline to Month 1 (i.e. for up to 1 month)
  2. Change From Baseline to Month 3 in Wake After Sleep Onset (WASO)Time frame: From baseline to Month 3 (i.e. for up to 3 months)
  3. Change From Baseline to Month 1 in Latency to Persistent Sleep (LPS) (Sleep Onset)Time frame: From baseline to Month 1 (i.e. for up to 1 month)
  4. Change From Baseline to Month 3 in Latency to Persistent Sleep (LPS)Time frame: From baseline to Month 3 (i.e. for up to 3 months)

Locations

86 sites in 11 countries. Site status is shown where the registry gives one.

  • Pulmonary Associates, Pa

    Glendale, Arizona

  • Noble Clinical Research

    Tucson, Arizona

  • Baptist Health Center for Clinical Research

    Little Rock, Arkansas

  • Woodland International Research Group

    Little Rock, Arkansas

  • Core Healthcare Group

    Cerritos, California

  • Artemis Institute For Clinical Research - Riverside

    Riverside, California

  • Pacific Research Network

    San Diego, California

  • Artemis Institute for Clinical Research

    San Marcos, California

  • Santa Monica Clinical Trials

    Santa Monica, California

  • Empire Clinical Research

    Upland, California

  • Innovative Clinical Research

    Lafayette, Colorado

  • Clinical Research of South Florida

    Coral Gables, Florida

  • Fleming Island Center for Clinical Research

    Fleming Island, Florida

  • Clinical Trials Research

    Lincoln, Florida

  • Clinical Research Group of St. Petersburgh

    St. Petersburg, Florida

  • Neurotrials Research Incorporated

    Atlanta, Georgia

  • Sleep Practitioners, LLC

    Macon, Georgia

  • Hawaii Pacific Neurosciences

    Honolulu, Hawaii

  • Saltzer Clinical Research

    Nampa, Idaho

  • Rowe Neurology Institute

    Lenexa, Kansas

  • Sleep Disorders Center of the Mid-Atlantic

    Glen Burnie, Maryland

  • Neurocare Inc.

    Newton, Massachusetts

  • Precise Research Centers

    Flowood, Mississippi

  • Garden City Asthma and Sleep Center

    Garden City, New York

  • Research Carolina of Hickory

    Hickory, North Carolina

  • Wake Research Associates

    Raleigh, North Carolina

  • Clinical Trials of America - NC, LLC

    Winston-Salem, North Carolina

  • CTI Clinical Research II

    Cincinnati, Ohio

  • Ohio Sleep Medicine Institue

    Dublin, Ohio

  • Cleveland Sleep Research Center

    Middleburg Heights, Ohio

  • Robert V. Sibilia, MD, Inc.

    Wooster, Ohio

  • Brian Abaluck LLC

    Paoli, Pennsylvania

  • Wesley Neurology Clinic Pc (Multiple Sclerosis)

    Cordova, Tennessee

  • FutureSearch Trials of Neurology, LP

    Austin, Texas

  • InSite Clinical Research

    DeSoto, Texas

  • Jacksonville Center for Clinical Research

    Jacksonville, Texas

  • Dm Clinical Research / Martin Diagnostic Clinic

    Tomball, Texas

  • HOSPITAL AZ SINT-JAN_Neurology department

    Bruges, Belgium

  • Hospital Universitair Zieknhuis Brussel, Pneumology and Sleep Laboratory

    Brussels, Belgium

  • University Hospital Gent, Department of General Internal Medicine and Center of neurophysiological Monitoring

    Ghent, Belgium

Showing 40 of 86 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.